Cpf1 Discovery Unlikely to Affect the...
Looking Ahead after the Approval of...
RNA-Seq and SCA Could Have a...
Predictive Diagnostic Tests Are Continuing To...
Updated: Dec 15 2011
Procognia (Israel) Ltd. is a world leader in glycobiology, with an exclusive range of proprietary technologies and applications covering four key platforms: analytics, diagnostics, therapeutic antibodies and stem cells.
Do you think that sustainability considerations should be incorporated into the new Dietary Guidelines for Americans?
Be sure to add email@example.com
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2015 Genetic Engineering & Biotechnology News All Rights Reserved